Metacognitive Therapy Reduces Anxiety, Depression in Heart Disease Patients

PLOS

Self-help metacognitive therapy – which aims to reduce rumination – significantly reduces anxiety and depression symptoms in recovering heart disease patients, according to new randomized controlled trial

In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004161

Article Title: Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial

Author Countries: United KingdomFunding: This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) Programme (Grant Reference Number RP-PG-1211-20011). AW was awarded the grant. https://fundingawards.nihr.ac.uk/award/RP-PG-1211-20011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.

You might also like